Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 08, 2017 Filed Dec 28, 2017 14:57 UTC |
Ranoux Claude10% owner
|
SaleINVO Bioscience Common Stock | 50,000 | $0.30 | $15,000.00 |
DisclosureSEC source: 0001479791-17-000005 · primary_doc.xml · nonDerivative · entry 2 Ranoux Claude · CIK 0001479791 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,423,122 Read SEC document |
| August 08, 2017 Filed Dec 28, 2017 14:57 UTC |
Ranoux Claude10% owner
|
OtherINVO Bioscience Common Stock | 500,000 | $0.00 | $50.00 |
DisclosureSEC source: 0001479791-17-000005 · primary_doc.xml · nonDerivative · entry 1 Ranoux Claude · CIK 0001479791 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,473,122 Read SEC document |
| August 08, 2017 Filed Jan 31, 2018 16:25 UTC |
Ranoux Claude10% owner
|
SaleINVO Bioscience Common Stock | 140,000 | $0.05 | $7,000.00 |
DisclosureSEC source: 0001479791-18-000009 · primary_doc.xml · nonDerivative · entry 4 Ranoux Claude · CIK 0001479791 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,283,122 Read SEC document |
| August 08, 2017 Filed Jan 31, 2018 16:25 UTC |
Ranoux Claude10% owner
|
SaleINVO Bioscience Common Stock | 50,000 | $0.30 | $15,000.00 |
DisclosureSEC source: 0001479791-18-000009 · primary_doc.xml · nonDerivative · entry 3 Ranoux Claude · CIK 0001479791 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,423,122 Read SEC document |
| August 08, 2017 Filed Jan 31, 2018 16:25 UTC |
Ranoux Claude10% owner
|
OtherINVO Bioscience Common Stock | 500,000 | $0.00 | $50.00 |
DisclosureSEC source: 0001479791-18-000009 · primary_doc.xml · nonDerivative · entry 2 Ranoux Claude · CIK 0001479791 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,473,122 Read SEC document |
| June 19, 2017 Filed Dec 28, 2017 14:31 UTC |
Ranoux Claude10% owner
|
SaleINVO Bioscience Common Stock | 100,000 | $0.30 | $30,000.00 |
DisclosureSEC source: 0001479791-17-000004 · primary_doc.xml · nonDerivative · entry 1 Ranoux Claude · CIK 0001479791 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,973,122 Read SEC document |
| June 19, 2017 Filed Jan 31, 2018 16:25 UTC |
Ranoux Claude10% owner
|
SaleINVO Bioscience Common Stock | 100,000 | $0.30 | $30,000.00 |
DisclosureSEC source: 0001479791-18-000009 · primary_doc.xml · nonDerivative · entry 1 Ranoux Claude · CIK 0001479791 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,973,122 Read SEC document |
| February 15, 2017 Filed Jul 3, 2017 14:58 UTC |
Karloff Kathleen tDirector · CEO / Chairman
|
SaleINVO Bioscience Common Stock Restricted | 400,000 | $0.15 | $60,000.00 |
DisclosureSEC source: 0001185185-17-001502 · form4-karloff062817.xml · nonDerivative · entry 1 Karloff Kathleen t · CIK 0001493763 · Director · CEO / Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,760,000 Read SEC document |
| May 26, 2016 Filed Jul 3, 2017 14:47 UTC |
Bowdring Robert Joseph JrDirector
|
GrantINVO Bioscience Common Stock (Restricted) | 1,000,000 | $0.36 | $360,000.00 |
DisclosureSEC source: 0001185185-17-001498 · form5-bowdring123116.xml · nonDerivative · entry 1 Bowdring Robert Joseph Jr · CIK 0001664410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,500,000 Read SEC document |
| May 26, 2016 Filed Jul 3, 2017 15:21 UTC |
Karloff Kathleen tDirector · CEO/Chairman
|
GrantINVO Bioscience Common Stock Restricted | 1,000,000 | $0.36 | $360,000.00 |
DisclosureSEC source: 0001185185-17-001516 · form5-karloff123116.xml · nonDerivative · entry 2 Karloff Kathleen t · CIK 0001493763 · Director · CEO/Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,160,000 Read SEC document |
| May 26, 2016 Filed Jul 27, 2017 13:47 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
GrantINVO Bioscience Common Stock (Restricted) | 1,000,000 | $0.36 | $360,000.00 |
DisclosureSEC source: 0001511164-17-000436 · primary_doc.xml · nonDerivative · entry 7 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,073,122 Read SEC document |
| March 04, 2016 Filed Jul 3, 2017 15:21 UTC |
Karloff Kathleen tDirector · CEO/Chairman
|
Disposition to issuerINVO Bioscience Common Stock Restricted | 1,000,000 | $0.30 | $300,000.00 |
DisclosureSEC source: 0001185185-17-001516 · form5-karloff123116.xml · nonDerivative · entry 1 Karloff Kathleen t · CIK 0001493763 · Director · CEO/Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,160,000 Read SEC document |
| January 25, 2016 Filed Jul 27, 2017 13:47 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Restricted) | 1,200 | $0.50 | $600.00 |
DisclosureSEC source: 0001511164-17-000436 · primary_doc.xml · nonDerivative · entry 6 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,073,122 Read SEC document |
| January 25, 2016 Filed Jul 27, 2017 13:47 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Restricted) | 5,500 | $0.55 | $3,025.00 |
DisclosureSEC source: 0001511164-17-000436 · primary_doc.xml · nonDerivative · entry 5 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,074,322 Read SEC document |
| January 25, 2016 Filed Jul 27, 2017 13:47 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Restricted) | 30,000 | $0.70 | $21,000.00 |
DisclosureSEC source: 0001511164-17-000436 · primary_doc.xml · nonDerivative · entry 4 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,079,822 Read SEC document |
| January 25, 2016 Filed Jul 27, 2017 13:47 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Restricted) | 11,111 | $0.45 | $4,999.95 |
DisclosureSEC source: 0001511164-17-000436 · primary_doc.xml · nonDerivative · entry 3 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,109,822 Read SEC document |
| January 25, 2016 Filed Jul 27, 2017 13:47 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Restricted) | 15,000 | $0.40 | $6,000.00 |
DisclosureSEC source: 0001511164-17-000436 · primary_doc.xml · nonDerivative · entry 2 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,140,933 Read SEC document |
| January 25, 2016 Filed Jul 27, 2017 13:47 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Restricted) | 20,000 | $0.35 | $7,000.00 |
DisclosureSEC source: 0001511164-17-000436 · primary_doc.xml · nonDerivative · entry 1 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,135,933 Read SEC document |
| June 29, 2015 Filed Jul 27, 2017 13:28 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Restricted) | 2,500 | $0.40 | $1,000.00 |
DisclosureSEC source: 0001511164-17-000432 · primary_doc.xml · nonDerivative · entry 6 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,155,933 Read SEC document |
| June 29, 2015 Filed Jul 27, 2017 13:28 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Restricted) | 3,750 | $0.40 | $1,500.00 |
DisclosureSEC source: 0001511164-17-000432 · primary_doc.xml · nonDerivative · entry 5 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,158,433 Read SEC document |
| June 29, 2015 Filed Jul 27, 2017 13:28 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Restricted) | 120,000 | $0.25 | $30,000.00 |
DisclosureSEC source: 0001511164-17-000432 · primary_doc.xml · nonDerivative · entry 4 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,162,183 Read SEC document |
| March 17, 2015 Filed Jul 27, 2017 13:28 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Restricted) | 125,000 | $0.20 | $25,000.00 |
DisclosureSEC source: 0001511164-17-000432 · primary_doc.xml · nonDerivative · entry 3 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,282,183 Read SEC document |
| January 16, 2015 Filed Jul 27, 2017 13:28 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Restricted) | 50,000 | $0.10 | $5,000.00 |
DisclosureSEC source: 0001511164-17-000432 · primary_doc.xml · nonDerivative · entry 2 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,407,183 Read SEC document |
| January 02, 2015 Filed Jul 27, 2017 13:28 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Restricted) | 1,100,000 | $0.05 | $55,000.00 |
DisclosureSEC source: 0001511164-17-000432 · primary_doc.xml · nonDerivative · entry 1 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,457,183 Read SEC document |
| November 05, 2014 Filed Jul 3, 2017 14:44 UTC |
Bowdring Robert Joseph JrDirector
|
GrantINVO Bioscience Common Stock (Restricted) | 3,000,000 | $0.15 | $450,000.00 |
DisclosureSEC source: 0001185185-17-001496 · form5-bowdring123114.xml · nonDerivative · entry 1 Bowdring Robert Joseph Jr · CIK 0001664410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,500,000 Read SEC document |
| November 05, 2014 Filed Jul 3, 2017 15:18 UTC |
Karloff Kathleen tDirector · CEO · 10% owner
|
GrantINVO Bioscience Common Stock Restricted | 2,000,000 | $0.02 | $30,000.00 |
DisclosureSEC source: 0001185185-17-001514 · form5-karloff123114.xml · nonDerivative · entry 3 Karloff Kathleen t · CIK 0001493763 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,160,000 Read SEC document |
| November 05, 2014 Filed Jul 27, 2017 12:04 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
GrantINVO Bioscience Common Stock (Restricted) | 2,000,000 | $0.15 | $300,000.00 |
DisclosureSEC source: 0001511164-17-000431 · primary_doc.xml · nonDerivative · entry 10 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,557,183 Read SEC document |
| October 29, 2014 Filed Jul 27, 2017 12:04 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Restricted) | 12,500 | $0.08 | $1,000.00 |
DisclosureSEC source: 0001511164-17-000431 · primary_doc.xml · nonDerivative · entry 9 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,557,183 Read SEC document |
| October 29, 2014 Filed Jul 27, 2017 12:04 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Restricted) | 12,500 | $0.08 | $1,000.00 |
DisclosureSEC source: 0001511164-17-000431 · primary_doc.xml · nonDerivative · entry 8 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,569,683 Read SEC document |
| October 29, 2014 Filed Jul 27, 2017 12:04 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Restricted) | 100,000 | $0.08 | $8,000.00 |
DisclosureSEC source: 0001511164-17-000431 · primary_doc.xml · nonDerivative · entry 7 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,582,183 Read SEC document |
| October 14, 2014 Filed Jul 27, 2017 12:04 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Restricted) | 15,000 | $0.10 | $1,500.00 |
DisclosureSEC source: 0001511164-17-000431 · primary_doc.xml · nonDerivative · entry 6 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,682,183 Read SEC document |
| October 14, 2014 Filed Jul 27, 2017 12:04 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Restricted) | 250,000 | $0.04 | $10,000.00 |
DisclosureSEC source: 0001511164-17-000431 · primary_doc.xml · nonDerivative · entry 5 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,697,183 Read SEC document |
| September 30, 2014 Filed Jul 27, 2017 12:04 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Restricted) | 200,000 | $0.05 | $10,000.00 |
DisclosureSEC source: 0001511164-17-000431 · primary_doc.xml · nonDerivative · entry 4 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,947,183 Read SEC document |
| August 27, 2014 Filed Jul 27, 2017 12:04 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Restricted) | 200,000 | $0.05 | $10,000.00 |
DisclosureSEC source: 0001511164-17-000431 · primary_doc.xml · nonDerivative · entry 3 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,147,183 Read SEC document |
| June 26, 2014 Filed Jul 3, 2017 15:18 UTC |
Karloff Kathleen tDirector · CEO · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock Restricted | 400,000 | $0.03 | $12,000.00 |
DisclosureSEC source: 0001185185-17-001514 · form5-karloff123114.xml · nonDerivative · entry 2 Karloff Kathleen t · CIK 0001493763 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,160,000 Read SEC document |
| June 13, 2014 Filed Jul 3, 2017 15:18 UTC |
Karloff Kathleen tDirector · CEO · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock Restricted | 400,000 | $0.03 | $12,000.00 |
DisclosureSEC source: 0001185185-17-001514 · form5-karloff123114.xml · nonDerivative · entry 1 Karloff Kathleen t · CIK 0001493763 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,560,000 Read SEC document |
| January 10, 2014 Filed Jul 27, 2017 12:04 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Restricted) | 200,000 | $0.05 | $10,000.00 |
DisclosureSEC source: 0001511164-17-000431 · primary_doc.xml · nonDerivative · entry 2 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,347,183 Read SEC document |
| January 07, 2014 Filed Jul 27, 2017 12:04 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Restricted) | 325,000 | $0.05 | $14,950.00 |
DisclosureSEC source: 0001511164-17-000431 · primary_doc.xml · nonDerivative · entry 1 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,547,183 Read SEC document |
| April 01, 2013 Filed Jul 27, 2017 11:42 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Restricted) | 325,000 | $0.04 | $14,365.00 |
DisclosureSEC source: 0001511164-17-000430 · primary_doc.xml · nonDerivative · entry 3 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,872,183 Read SEC document |
| February 05, 2013 Filed Jul 3, 2017 14:41 UTC |
Bowdring Robert Joseph JrChief Financial Officer
|
GrantINVO Bioscience Common Stock (Restricted) | 4,000,000 | $0.01 | $20,000.00 |
DisclosureSEC source: 0001185185-17-001494 · form5-bowdring123113.xml · nonDerivative · entry 1 Bowdring Robert Joseph Jr · CIK 0001664410 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,500,000 Read SEC document |
| February 05, 2013 Filed Jul 3, 2017 15:17 UTC |
Karloff Kathleen tDirector · CEO/Chairman
|
GrantINVO Bioscience Common Stock (Restricted) | 4,000,000 | $0.01 | $20,000.00 |
DisclosureSEC source: 0001185185-17-001512 · form5-karloff123113.xml · nonDerivative · entry 1 Karloff Kathleen t · CIK 0001493763 · Director · CEO/Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,960,000 Read SEC document |
| February 05, 2013 Filed Jul 27, 2017 11:42 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
GrantINVO Bioscience Common Stock (Restricted) | 4,000,000 | $0.01 | $20,000.00 |
DisclosureSEC source: 0001511164-17-000430 · primary_doc.xml · nonDerivative · entry 2 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,197,183 Read SEC document |
| January 15, 2013 Filed Jul 27, 2017 11:42 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Restricted) | 350,000 | $0.06 | $21,000.00 |
DisclosureSEC source: 0001511164-17-000430 · primary_doc.xml · nonDerivative · entry 1 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,197,183 Read SEC document |
| October 09, 2012 Filed Jul 27, 2017 11:22 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Restricted) | 500,000 | $0.06 | $30,000.00 |
DisclosureSEC source: 0001511164-17-000429 · primary_doc.xml · nonDerivative · entry 20 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,547,183 Read SEC document |
| July 30, 2012 Filed Jul 27, 2017 11:22 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Restricted) | 150,000 | $0.06 | $9,000.00 |
DisclosureSEC source: 0001511164-17-000429 · primary_doc.xml · nonDerivative · entry 19 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,047,183 Read SEC document |
| March 29, 2012 Filed Jul 27, 2017 11:22 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Restricted) | 20,000 | $0.02 | $420.00 |
DisclosureSEC source: 0001511164-17-000429 · primary_doc.xml · nonDerivative · entry 18 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,197,183 Read SEC document |
| March 29, 2012 Filed Jul 27, 2017 11:22 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Restricted) | 12,750 | $0.02 | $255.00 |
DisclosureSEC source: 0001511164-17-000429 · primary_doc.xml · nonDerivative · entry 17 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,217,183 Read SEC document |
| March 26, 2012 Filed Jul 27, 2017 11:22 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Restricted) | 10,000 | $0.02 | $230.00 |
DisclosureSEC source: 0001511164-17-000429 · primary_doc.xml · nonDerivative · entry 16 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,229,933 Read SEC document |
| March 16, 2012 Filed Jul 27, 2017 11:22 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Restricted) | 30,000 | $0.02 | $600.00 |
DisclosureSEC source: 0001511164-17-000429 · primary_doc.xml · nonDerivative · entry 15 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,239,933 Read SEC document |
| January 26, 2012 Filed Jul 27, 2017 11:22 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Restricted) | 3,000 | $0.05 | $159.00 |
DisclosureSEC source: 0001511164-17-000429 · primary_doc.xml · nonDerivative · entry 14 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,269,933 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.